- Wednesday, April 3, 2024
7:00 AM – 8:00 AM ET
CE Symposium: Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists
7:00 AM – 8:00 AM ET
CE Symposium: Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology PharmacistsLocation: 120-121Co-Speaker: – University of California, Irvine
Co-Speaker: – University of Georgia College of Pharmacy
Co-Speaker: – Mayo Clinic
Shawn P. Griffin, PharmD, BCOP (he/him/his) – University of California, Irvine ### 1772980###Co-Speaker###Assistant Clinical Professor###University of California, Irvine###Co-Speaker: – University of California, Irvine
### he/him/his @@@ Amber Bradley Clemmons, PharmD, BCOP, FHOPA (she/her/hers) – University of Georgia College of Pharmacy ### 1177736###Co-Speaker###Clinical Professor###University of Georgia College of Pharmacy###Co-Speaker: – University of Georgia College of Pharmacy
### she/her/hers @@@ Kristen McCullough, PharmD, MS, BCPS, BCOP – Mayo Clinic ### 2127684###Co-Speaker###Hematology Clinical Pharmacy Specialist###Mayo Clinic###Co-Speaker: – Mayo Clinic
### 7:00 AM – 8:00 AM ET
CE Symposium: Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody Platforms
7:00 AM – 8:00 AM ET
CE Symposium: Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody PlatformsLocation: 124-125*Speaker: – Emory University School of Medicine
*Speaker: – University of Kansas Cancer Center
*Speaker: – Medical University of South Carolina
R. Donald Harvey, III, PharmD, BCOP, FCCP, FHOPA, FASCO – Emory University School of Medicine ### 1464551###*Speaker###Professor###Emory University School of Medicine###*Speaker: – Emory University School of Medicine
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA (she/her/hers) – University of Kansas Cancer Center ### 958456###*Speaker###Clinical Pharmacy Manager###University of Kansas Cancer Center###*Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ James A. Davis, PharmD, BCOP – Medical University of South Carolina ### 1810470###*Speaker###Clinical Pharmacy Specialist – Malignant Hematology & Assistant Professor - MUSC College of Pharmacy###Medical University of South Carolina###*Speaker: – Medical University of South Carolina
### 7:00 AM – 8:00 AM ET
CE Symposium:Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operational Efficiency in Multiple Myeloma
7:00 AM – 8:00 AM ET
CE Symposium: Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operational Efficiency in Multiple MyelomaLocation: 122-123Co-Speaker: – University of Michigan Rogel Cancer Center
Co-Speaker:
Co-Speaker: – Moffitt Cancer Center
Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###Co-Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###Co-Speaker: – University of Michigan Rogel Cancer Center
### @@@ Joseph A. Kalis, PharmD, BCOP ### 2269369###Co-Speaker#########Co-Speaker:
### @@@ Rebecca Gonzalez, PharmD, BCOP (she/her/hers) – Moffitt Cancer Center ### 900574###Co-Speaker###Clinical Pharmacist in Blood and Marrow Transplant/Cellular Immunotherapy###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers8:00 AM – 12:00 PM ET
Pre-conference: From Data to Decisions: A Masterclass in Critical Appraisal of Cancer Research
8:00 AM – 12:00 PM ET
001 - Pre-conference: From Data to Decisions: A Masterclass in Critical Appraisal of Cancer ResearchLocation: Room 114-117Co-Speaker: – University of Michigan College of Pharmacy
Co-Speaker: – University of Michigan
Co-Speaker: – University of California San Diego
Bernard L. Marini, PharmD, BCOP (he/him/his) – University of Michigan College of Pharmacy ### 1254284###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan College of Pharmacy###Co-Speaker: – University of Michigan College of Pharmacy
### he/him/his @@@ Anthony J. Perissinotti, PharmD, BCOP – University of Michigan ### 1486423###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan###Co-Speaker: – University of Michigan
### @@@ Aaron Goodman, MD – University of California San Diego ### 2128381###Co-Speaker###Associate Professor of Medicine Division###University of California San Diego###Co-Speaker: – University of California San Diego
###
12:00 PM – 1:00 PM ET
Non-CE Symposium: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?
12:00 PM – 1:00 PM ET
Non-CE Symposium: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?Location: 122-123
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP ### 957901###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Brukinsa (zanubrutinib) for the treatment of adult patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
12:00 PM – 1:00 PM ET
Non-CE Symposium: Brukinsa (zanubrutinib) for the treatment of adult patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Location: 124-125
Bhavesh Shah, RPh BCOP ### 957886###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM ET
Non-CE Symposium: Outcomes and Economic Impact of Treatment with CABLIVI®(caplacizumab-yhdp)
12:00 PM – 1:00 PM ET
Non-CE Symposium: Outcomes and Economic Impact of Treatment with CABLIVI®(caplacizumab-yhdp)Location: 120-121
Hillary Maitland, MD, MS ### 2251086###*Speaker#########*Speaker:
### @@@ Adam Gurry, MD, MS ### 2251087###*Speaker#########*Speaker:
### 1:15 PM – 2:30 PM ET
Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical Trials
1:15 PM – 2:30 PM ET
BC1 - Diving into DEI: Increasing Inclusivity and Fostering Diversity in Clinical TrialsLocation: Ballroom B-CCo-Speaker: – UC Davis Health
Co-Speaker: – Stanford Health Care
Co-Speaker: – UCSF
Jennifer A. Murphy, PharmD, BCOP – UC Davis Health ### 2127665###Co-Speaker###Senior Pharmacist, Oncology & Investigational Drug Service###UC Davis Health###Co-Speaker: – UC Davis Health
### @@@ Elyse A. MacDonald, PharmD, BCPS, MS – Stanford Health Care ### 2127677###Co-Speaker###Director, Investigational Drug Service###Stanford Health Care###Co-Speaker: – Stanford Health Care
### @@@ Lisa Janssen Carlson, PharmD, BCOP (she/her/hers) – UCSF ### 2127664###Co-Speaker###Investigational Drug Services Manager###UCSF###Co-Speaker: – UCSF
### she/her/hers
1:15 PM – 2:30 PM ET
Updates in Hematology
1:15 PM – 2:30 PM ET
101 - Updates in HematologyLocation: Ballroom DSpeaker: – Methodist University Hospital
Dennis Marjoncu, PharmD, BCOP (he/him/his) – Methodist University Hospital ### 1171480###Speaker###Clinical Pharmacy Specialist###Methodist University Hospital###Speaker: – Methodist University Hospital
### he/him/his
2:45 PM – 3:30 PM ET
President's Welcome
2:45 PM – 3:30 PM ET
President's Welcome and Recognition of HOPA FellowsLocation: Ballroom B-C*Speaker: – Atrium Health Wake Forest Baptist (WFB)
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###*Speaker###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###*Speaker: – Atrium Health Wake Forest Baptist (WFB)
### 3:45 PM – 4:45 PM ET
Platform Research Part 1 of 4: The REMEDY Trial: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy
3:45 PM – 4:45 PM ET
102-A - Platform Research Part 1 of 4: The REMEDY Trial: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation ChemotherapyLocation: Ballroom DCo-Speaker: – University of Georgia College of Pharmacy
Co-Speaker: – Wellstar MCG Health
Amber Bradley Clemmons, PharmD, BCOP, FHOPA (she/her/hers) – University of Georgia College of Pharmacy ### 1177736###Co-Speaker###Clinical Professor###University of Georgia College of Pharmacy###Co-Speaker: – University of Georgia College of Pharmacy
### she/her/hers @@@ Emily Behren Ketchum, PharmD, BCOP (she/her/hers) – Wellstar MCG Health ### 1553112###Co-Speaker###Heme/BMT Ambulatory Oncology Pharmacy Specialist ###Wellstar MCG Health###Co-Speaker: – Wellstar MCG Health
### she/her/hers
3:45 PM – 4:45 PM ET
Platform Research Part 2 of 4: Post-Transplant Cyclophosphamide As GVHD Prevention After Myeloablative Conditioning
3:45 PM – 4:45 PM ET
102-B - Platform Research Part 2 of 4: Post-Transplant Cyclophosphamide As GVHD Prevention After Myeloablative ConditioningLocation: Ballroom DCo-Speaker: – Duke University Hospital
Co-Speaker: – Duke University Hospital
Mary C. Cash, PharmD, BCOP – Duke University Hospital ### 1553147###Co-Speaker###Clinical Oncology Pharmacist, Adult Bone Marrow Transplant and Cellular Therapy###Duke University Hospital###Co-Speaker: – Duke University Hospital
### @@@ Erin M. Eberwein, PharmD, BCOP – Duke University Hospital ### 2229003###Co-Speaker###Clinical Oncology Pharmacist, Bone Marrow Transplant and Cellular Therapy###Duke University Hospital###Co-Speaker: – Duke University Hospital
###
3:45 PM – 4:45 PM ET
Platform Research Part 3 of 4: Survey of PGY-2 Oncology RPDs To Assess Resources and Effects on Burnout
3:45 PM – 4:45 PM ET
102-C - Platform Research Part 3 of 4: Survey of PGY-2 Oncology RPDs To Assess Resources and Effects on BurnoutLocation: Ballroom DSpeaker: – Roswell Park Comprehensive Cancer Center
Eugene R. Przespolewski, PharmD, BCOP, DPLA (he/him/his) – Roswell Park Comprehensive Cancer Center ### 2188549###Speaker###Clinical Pharmacist Specialist, Residency Program Director###Roswell Park Comprehensive Cancer Center###Speaker: – Roswell Park Comprehensive Cancer Center
### he/him/his
3:45 PM – 4:45 PM ET
Platform Research Part 4 of 4: Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib
3:45 PM – 4:45 PM ET
102-D - Platform Research Part 4 of 4: Predictive Factors of Dose Reduction Among Patients Treated With PalbociclibLocation: Ballroom DSpeaker: – CIUSSS de l'Est-de-l'Île-de-Montréal
Sandra Savignac, PharmD, M.Sc (she/her/hers) – CIUSSS de l'Est-de-l'Île-de-Montréal ### 2188537###Speaker###Oncology Pharmacist###CIUSSS de l'Est-de-l'Île-de-Montréal###Speaker: – CIUSSS de l'Est-de-l'Île-de-Montréal
### she/her/hers
3:45 PM – 4:45 PM ET
Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of Toxicities
3:45 PM – 4:45 PM ET
103 - Updates in Hodgkin Lymphoma and the Role of the Pharmacist in Management of ToxicitiesLocation: Ballroom ASpeaker: – University of Miami Sylvester Comprehensive Cancer Center
Co-Speaker: – Miami Cancer Institute | Baptist Health South Florida
Matthew Chui, PharmD, BCOP – University of Miami Sylvester Comprehensive Cancer Center ### 2144501###Speaker###Clinical Oncology Pharmacy Manager###University of Miami Sylvester Comprehensive Cancer Center###Speaker: – University of Miami Sylvester Comprehensive Cancer Center
### @@@ Tiba Al Sagheer, PharmD, BCOP, BCACP (she/her/hers) – Miami Cancer Institute | Baptist Health South Florida ### 2144502###Co-Speaker###Clinical Pharmacy Specialist###Miami Cancer Institute | Baptist Health South Florida###Co-Speaker: – Miami Cancer Institute | Baptist Health South Florida
### she/her/hers
3:45 PM – 4:45 PM ET
Waiting For The Rain: Practical Strategies And Ethical Considerations During Anticancer Drug Droughts
3:45 PM – 4:45 PM ET
104 - Waiting For The Rain: Practical Strategies And Ethical Considerations During Anticancer Drug Droughts Location: Ballroom B-CCo-Speaker: – Aurora Heath Care
Co-Speaker: – The Ohio State University Wexner Medical Center
Co-Speaker:
Peter Stuessy, PharmD, BCOP (he/him/his) – Aurora Heath Care ### 2127674###Co-Speaker###Clinical Pharmacy Specialist - Oncology###Aurora Heath Care###Co-Speaker: – Aurora Heath Care
### he/him/his @@@ Jeff Pilz, PharmD, BCPS, MPA, MS – The Ohio State University Wexner Medical Center ### 1518389###Co-Speaker###Assistant Director of Pharmacy - Medication Safety and Policy###The Ohio State University Wexner Medical Center###Co-Speaker: – The Ohio State University Wexner Medical Center
### @@@ Michael Harrison ### 2188452###Co-Speaker###Patient Advocate and Cancer Survivor######Co-Speaker:
###
4:45 PM – 7:00 PM ET
Exhibit Hall Welcome Reception and Industry Encore Posters
4:45 PM – 7:00 PM ET
Exhibit Hall Welcome Reception and Industry Encore Posters
Location: Exhibit Hall
5:30 PM – 6:30 PM ET
Non-CE Symposium: Managing Patients with locally advanced or metastatic KRAS G12C-mutated NSCLC
5:30 PM – 6:30 PM ET
Non-CE Symposium: Managing Patients with locally advanced or metastatic KRAS G12C-mutated NSCLCLocation: 122-123
Hatim Husain, MD ### 2262370###*Speaker#########*Speaker:
### 5:30 PM – 6:30 PM ET
Non-CE Symposium: Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case-Based Symposium on Care Team Preparation and Patient Management
5:30 PM – 6:30 PM ET
Non-CE Symposium: Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Case-Based Symposium on Care Team Preparation and Patient Management Location: 120-121*Speaker: – Menarini Stemline
*Speaker: – Menarini Stemline
Rebecca Nelson, PharmD, BCOP – Menarini Stemline ### 2251093###*Speaker######Menarini Stemline###*Speaker: – Menarini Stemline
### @@@ Dylan Barth, PharmD – Menarini Stemline ### 2251095###*Speaker######Menarini Stemline###*Speaker: – Menarini Stemline
### 6:00 PM – 8:00 PM ET
AC24 Service Project: HOPA CAN Help Prevent HIV
6:00 PM – 8:00 PM ET
AC24 Service Project: HOPA CAN Help Prevent HIV
Location: 118 - 119
